A Phase I, Double-blind, Placebo-controlled, Ascending Single-dose, Safety, Tolerability and Pharmacokinetic Study of QGC001 in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 13 Dec 2013
At a glance
- Drugs QGC 001 (Primary)
- Indications Hypertension
- Focus Adverse reactions; First in man
- Sponsors Quantum Genomics
- 10 Jun 2017 Biomarkers information updated
- 18 Jul 2013 New source identified and integrated: ClincalTrials.gov record.
- 19 Oct 2012 Status changed from recruiting to completed, as reported in a Quantum Genomics media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History